Investing Port

Цена ао	102.7
P/E	21.73
P/S	3.97
P/BV	11.66
EV/EBITDA	16.83
Дивиденд ао	5.2
Див.доход ао	5.16
EBITDA	18.37

Institutions	Объем	Доля, %
First Trust Portfolios L.P.	771002	0.04
Guggenheim Funds Distributors, LLC	275	0
Invesco Capital Markets Inc	241	0
Advisors Asset Management, Inc.	395329	0.02
Sabrient Systems	87105	0
Fidelity Management & Research Company	46559381	3.15
BlackRock Fund Advisors	37829044	2.14
Transamerica Asset Management, Inc	3475145	0.2
Security Investors, LLC	396549	0.02
Putnam Investment Management, LLC	5519302	0.31
Hennion & Walsh, Inc	1000	0
WisdomTree Asset Management Inc	2325190	0.13
Orbis Investment Management Limited	6894487	0.47
SunAmerica Asset Management, LLC	6926243	0.47
Voya Investments, LLC	3527845	0.2
DWS Investment S.A.	2912187	0.16
Nordea Investment Management AB	2349547	0.13
Nuveen Fund Advisors, LLC.	2339950	0.13
BlackRock Advisors (UK) Limited	7179687	0.49
Levin Capital Strategies, L.P.	26081	0
Fidelity Management & Research Company LLC	43778850	2.48
Fidelity SelectCo, LLC	12369290	0.7
UBS Asset Management	3093122	0.18
T. Rowe Price	13698044	0.78
Invesco Capital Management LLC	2772994	0.16

ETF	Доля, %
Health Care Select Sector SPDR Fund	4.13

On October 19, 2011, Abbott Laboratories announced its plan to separate into two publicly traded companies. The «new» Abbott Laboratories would specialize in diversified products including medical devices, diagnostic equipment and nutrition products, while AbbVie would operate as a research-based pharmaceutical manufacturer